It would make a lot of sense now that IMU is having CAR-T as one of its pipelines. CHM's Brain Cancer and NK-cell technologies are both close to start their registrational trials, that would mean in 2025 IMU could have 4 Rego trials. Imagine, if all 4 would be approved in 2026 / 2027.
CHM is atm valued worthless, but the GBM CAR-T is atm the most advanced GBM treatment - Imagine that! Then they are doing an NK-Cell AML trial in the US, approached by MD Anderson Texas due to fantastic ph 1 / 2 results. Again, CHM valued worthless.
Plus they got the green light to start the first ever direct attacking solid cancer CAR-T based on CD 17. That alone is more worth than $ ZERO.
And Hopper holds 19.99% of CHM. A t/o at 20c, about 200m EV, would make him a bit richer too. And me too, LOL.
GLTA
It would make a lot of sense now that IMU is having CAR-T as one...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $424.5M | |||
| Open | High | Low | Value | Volume |
| 5.8¢ | 5.8¢ | 5.6¢ | $1.032M | 18.08M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 90000 | 5.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 744737 | 5 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
5.8¢ |
Change
0.000 ( 1.03 %) |
||||
| Open | High | Low | Volume | ||
| 5.8¢ | 5.8¢ | 5.6¢ | 4924782 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| IMU (ASX) Chart |